Lambert-Eaton Myasthenic Syndrome — Research Summary
Printed from RareWays (rareways.com.au) on 24 September 2026
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Lambert-Eaton myasthenic syndrome: Why CMAP and reflexes are not enough.
Messina Christian — Journal of neuroimmunology (1 September 2026)
https://pubmed.ncbi.nlm.nih.gov/42150250/
- 2.
Rituximab for autoimmune myasthenic syndromes: a retrospective cohort study in myasthenia gravis and Lambert-Eaton myasthenic syndrome
Chamani Cheri R et al. (21 August 2026)
https://doi.org/10.64898/2026.08.18.26360320
- 3.
Plasma Exchange-Responsive Bulbar Dysfunction in Thymoma-Associated Myasthenia Gravis with Concomitant Lambert-Eaton Myasthenic Syndrome.
Hayashi Ryuichiro et al. — Internal medicine (Tokyo, Japan) (19 August 2026)
https://pubmed.ncbi.nlm.nih.gov/42618265/
- 4.
Longitudinal overview of symptomatic and immunosuppressive drugs in LEMS.
Bakker Wisse R et al. — Journal of neuromuscular diseases (17 August 2026)
https://pubmed.ncbi.nlm.nih.gov/42606021/
- 5.
Diagnosis of Lambert-Eaton myasthenic syndrome: Muscle fatigue with normal manual muscle testing, areflexia, and electrodiagnostic findings.
Handa Hideo et al. — Journal of neuroimmunology (1 August 2026)
https://pubmed.ncbi.nlm.nih.gov/41926836/
Clinical Trials — Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials.
- 1.
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Recruiting — Sanford Health
https://clinicaltrials.gov/study/NCT01793168
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Lambert-Eaton Myasthenic Syndrome
Lambert-Eaton myasthenic syndrome is a rare autoimmune condition in which antibodies disrupt the signal passing from nerves to muscles. It causes weakness in the hips and thighs, dry mouth and reduced reflexes, and is sometimes linked to small cell lung cancer. Care includes medicines that improve nerve signalling, immune therapies and treating any underlying tumour.
Most Recent Research
Common Questions
What is Lambert-Eaton Myasthenic Syndrome?
Lambert-Eaton myasthenic syndrome is a rare autoimmune condition in which antibodies disrupt the signal passing from nerves to muscles. It causes weakness in the hips and thighs, dry mouth and reduced reflexes, and is sometimes linked to small cell lung cancer. Care includes medicines that improve nerve signalling, immune therapies and treating any underlying tumour.
How many clinical trials are available for Lambert-Eaton Myasthenic Syndrome?
RareWays currently indexes 10 clinical trials for Lambert-Eaton Myasthenic Syndrome, of which 2 are actively recruiting. Trial availability changes as new studies are registered — check the trials tab for current status.
Where does the research data for Lambert-Eaton Myasthenic Syndrome come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is updated regularly by Rocky, RareWays' automated research engine. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Lambert-Eaton Myasthenic Syndrome.
No spam. Unsubscribe any time. Not medical advice.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.